Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort

Cancer Research and Treatment - Tập 49 Số 1 - Trang 44-53 - 2017
Minkyu Jung1, Jeeyun Lee2, Tae Min Kim3, Dae Ho Lee4, Jin‐Hyoung Kang5, Sung Young Oh6, Soo Jung Lee7, Sang Joon Shin1
1Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
2Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
3Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
4Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KOREA
5Division of Hematology-Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
6Department of Internal Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea
7Division of Hematology-Oncology, Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu, Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.3322/caac.21254

10.1093/annonc/mdv297

10.1186/1479-5876-12-116

10.1056/NEJMra041245

10.1056/NEJMoa1003466

10.1056/NEJMoa1103782

10.1200/JCO.2014.56.2736

10.1097/CMR.0000000000000185

10.1007/s10147-007-0751-1

10.5021/ad.2014.26.4.485

10.1186/1471-2407-11-85

10.1097/00008390-200412000-00016

10.1200/JCO.2009.23.4799

10.1007/s00262-014-1528-9

10.1097/CMR.0000000000000108

10.1001/archinte.166.17.1907

10.1016/j.jaad.2011.05.034

10.1634/theoncologist.2010-0067

10.1016/j.ejca.2013.09.007

10.1007/s00280-015-2873-x

10.1200/JCO.2014.57.4111

10.1038/bjc.2015.180

10.1093/annonc/mdt027

10.1007/s11060-014-1400-y

10.1200/JCO.2012.41.6750